← FDA DRUG APPROVALS

FDA ANDA · ANDA202329

LANTHANUM CARBONATE

Sponsor: ALKEM LABS LTD

APPLICATION
ANDA202329
TYPE
ANDA
ORIGINAL APPROVAL
2025-03-13
LATEST ACTION
2025-03-13
ROUTE
ORAL
DOSAGE FORM
TABLET, CHEWABLE
MARKETING STATUS
Prescription

Products

LANTHANUM CARBONATEPrescription
LANTHANUM CARBONATE EQ 1GM BASE · TABLET, CHEWABLE · ORAL
LANTHANUM CARBONATEPrescription
LANTHANUM CARBONATE EQ 500MG BASE · TABLET, CHEWABLE · ORAL
LANTHANUM CARBONATEPrescription
LANTHANUM CARBONATE EQ 750MG BASE · TABLET, CHEWABLE · ORAL

Approval history

2025-03-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →